πŸ‡ΊπŸ‡Έ FDA
Patent

US 8058226

Albumin-free factor VIII formulations

granted A61KA61K38/37A61K47/02

Quick answer

US patent 8058226 (Albumin-free factor VIII formulations) held by UNIVERSITY OF CONNECTICUT expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K38/37, A61K47/02, A61K47/10, A61K47/18